Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response

Cellular and Molecular Life Sciences

Volumn 60, Issue 3, 2003, Pages 607-616

  Hermann, H ^a   De Petrocellis, L ^c   Bisogno, T ^b   Moriello, A Schiano ^c   Lutz, B ^a   Di Marzo, V ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b Institute of Biomolecular Chemistry   (Italy)

^c CNR   (Italy)

Author keywords

Anandamide; Cannabinoid; Capsaicin; Pain; Receptor; Signalling; Vanilloid

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; ANANDAMIDE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CYCLIC AMP; DEXANABINOL; FORSKOLIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOLIPASE C INHIBITOR; RIMONABANT; VANILLOID RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EMBRYO; EMBRYO CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ARACHIDONIC ACIDS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CAPSAICIN; CYCLIC AMP; HUMANS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0344670180     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180300052     Document Type: Article

References (45)

1. Pertwee R. G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74: 129-180
2. Lutz B. (2002) Molecular biology of cannabinoid receptors. Prostaglandins Leukot. Essent. Fatty Acids 66: 123-142
3. Szallasi A. and Blumberg P. M. (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 51: 159-212
4. Ahluwalia J., Urban L., Capogna M., Bevan S. and Nagy I. (2000) Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100: 685-688
5. Caterina M. J., Leffler A., Malmberg A. B., Martin W. J., Trafton J., Petersen-Zeitz K. R. et al. (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313
6. Davis J. B., Gray J., Gunthorpe M. J., Hatcher J. P., Davey P. T., Overend P. et al. (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405: 183-187
7. Richardson J. D., Aanonsen L. and Hargreaves K. M. (1997) SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol. 319: R3-R4
8. Kelly S. and Chapman V. (2001) Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J. Neurophysiol. 86: 3061-3064
9. Mezey E., Toth Z. E., Cortright D. N., Arzubi M. K., Krause J. E., Elde R. et al. (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. USA 97: 3655-3660
10. Szabo T., Biro T., Gonzalez A. F., Palkovits M. and Blumberg P. M. (2002) Pharmacological characterization of vanilloid receptor located in the brain. Brain Res. Mol. Brain Res. 98: 51-57
11. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G. et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949
12. Zygmunt P. M., Petersson J., Andersson D. A., Chuang H., Sorgard M., Di Marzo V. et al. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457
13. Smart D., Gunthorpe M. J., Jerman J. C., Nasir S., Gray J., Muir A. I. et al. (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129: 227-230
14. Szallasi A. and Di Marzo V. (2000) New perspectives on enigmatic vanilloid receptors. Trends Neurosci. 23: 491-497
15. De Petrocellis L., Bisogno T., Maccarrone M., Davis J. B., Finazzi-Agrò A. and Di Marzo V. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 276: 12856-12863
16. De Petrocellis L., Harrison S., Bisogno T., Tognetto M., Brandi I., Smith G. D. et al. (2001) The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J. Neurochem 77: 1660-1663
17. Di Marzo V., Blumberg P. M. and Szallasi A. (2002) Endovanilloid signaling in pain. Curr. Opin. Neurobiol. 12: 372-379
18. Di Marzo V., Bisogno T., Melck D., Ross R., Brockie H., Stevenson L. et al. (1998) Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett. 436: 449-454
19. De Petrocellis L., Bisogno T., Davis J. B., Pertwee R. G. and Di Marzo V. (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 483: 52-56
20. Di Marzo V., Lastres-Becker I., Bisogno T., De Petrocellis L., Milone A., Davis J. B. et al. (2001) Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur. J. Pharmacol. 420: 123-131
21. Millns P. J., Chapman V. and Kendall D. A. (2001) Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. Br. J. Pharmacol. 132: 969-971
22. Melck D., Bisogno T., De Petrocellis L., Chuang H., Julius D., Bifulco M. et al. (1999) Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem. Biophys. Res. Commun. 262: 275-284
23. Di Marzo V., Bisogno T., De Petrocellis L., Brandi I., Jefferson R. G., Winckler R. L. et al. (2001) Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor 'hybrid' ligands. Biochem. Biophys. Res. Commun. 281: 444-451
24. Di Marzo V., Breivogel C., Bisogno T., Melck D., Patrick G., Tao Q. et al. (2000) Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. Eur. J. Pharmacol. 406: 363-374
25. Ross R. A., Gibson T. M., Brockie H. C., Leslie M., Pashmi G., Craib S. J. et al. (2001) Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol. 132: 631-640
26. Sambrook J., Fritsch E. F. and Maniatis T. (2001). Molecular Cloning (3rd edn), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
27. Marsicano G., Moosmann B., Hermann H., Lutz B. and Behl C. (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J. Neurochem. 80: 448-456
28. Huang S. M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F. et al. (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. USA 99: 8400-8405
29. Premkumar L.S. and Ahern G. P. (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408: 985-990
30. Vellani V., Mapplebeck S., Moriondo A., Davis J. B. and McNaughton P. A. (2001) Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J. Physiol. 534: 813-825
31. Chuang H. H., Prescott E. D., Kong H., Shields S., Jordt S. E., Basbaum A. I. et al. (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411: 957-962
32. 2- signals in cerebellar granule neurons in culture. J. Neurosci. 19: 8765-8777
33. + channels. Receptors Channels 6: 363-374
34. Gomez del Pulgar T., Velasco G. and Guzman M. (2000) The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem. J. 347: 369-373
35. Gomez Del Pulgar T., De Ceballos M. L., Guzman M. and Velasco G. (2002) Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 277: 36527-36533
36. Jordt S. E. and Julius D. (2002) Molecular basis for species-specific sensitivity to 'hot' chili peppers. Cell 108: 421-430
37. Ahluwalia J., Urban L., Bevan S. and Nagy I. (2002) The effect of anandamide on calcitonin gene-related peptide release from primary sensory neuron (abstract 375-P9). World Congress on Pain, p. 129, IASP, Seattle, Wash.
38. Greffrath W., Fischbach T., Nawrath H. and Treede R. D. (2002) Anandamide predominantly excites nociceptide dorsal root ganglion neurons of rats (abstract 381-P15). World Congress on Pain, p 131, IASP, Seattle, Wash.
39. Nemeth J., Helyes Z., Than M., Jakab B., Pinter E. and Szolcsanyi J. (2003) Concentration-dependent dual effect of anandamide on sensory neuropeptide release from isolated rat tracheae. Neurosci. Lett. 336: 89-92
40. Al-Hayani A., Wease K.N., Ross R.A., Pertwee R.G. and Davies S.N. (2001) The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41: 1000-1005.
41. Gauldie S. D., McQueen D. S., Pertwee R. and Chessell I. P. (2001) Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. Br. J. Pharmacol. 132: 617-621
42. Morisset V., Ahluwalia J., Nagy I. and Urban L. (2001) Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur. J. Pharmacol. 429: 93-100
43. Bhave G., Zhu W., Wang H., Brasier D. J., Oxford G. S. and Gereau R. W (2002). cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 35: 721-731
44. Rathee P. K., Distler C., Obreja O., Neuhuber W., Wang G. K., Wang S. Y. et al. (2002) PKA/AKAP/VR-1 module: a common link of Gs-mediated signaling to thermal hyperalgesia. J. Neurosci. 22: 4740-4745
45. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A. and Bisogno T. (2002) Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids 66: 377-391